Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
This important study examines the potential role of ARHGAP36 transcriptional regulation by FOXC1 in controlling sonic hedgehog signaling in human neuroblastoma. While there are many solid findings ...
Customizable nanomedicine platform shows promise for advancing personalized mRNA cancer therapeutics
Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...
The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.
On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
Fintel reports that on October 10, 2025, Morgan Stanley maintained coverage of Moderna (NasdaqGS:MRNA) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 76.50% Upside As of September ...
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...
Is it the invasion of the genome snatchers? Just in case the idea of aliens walking around in human skin suits wasn’t frightening enough. An outlandish study asserts that aliens might have abducted us ...
Please provide your email address to receive an email when new articles are posted on . Interferon lambda-encoding messenger RNA drug ETH47 was generally safe in healthy individuals. A phase 2a trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results